In an article in Managed Care, Jeremy Schafer discusses the findings from a recent breast cancer study reported in JAMA. The results help to validate that emerging drug therapies have played an important role in the declining mortality rates. However, health care stakeholders need to encourage utilization of treatments to deliver the best outcomes.

To read the full article, please click here.